Literature DB >> 23786404

Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw.

Vivek Thumbigere-Math1, Bryan S Michalowicz, James S Hodges, Michaela L Tsai, Karen K Swenson, Laura Rockwell, Rajaram Gopalakrishnan.   

Abstract

BACKGROUND: Previous case reports and animal studies suggest that periodontitis is associated with bisphosphonate-related osteonecrosis of the jaw (BRONJ). This case-control study is conducted to evaluate the association between clinical and radiographic measures of periodontal disease and BRONJ.
METHODS: Twenty-five patients with BRONJ were matched with 48 controls. Trained examiners measured probing depth, clinical attachment level (CAL), and bleeding on probing on all teeth except third molars and gingival and plaque indices on six index teeth. Alveolar bone height was measured from orthopantomograms. Most patients with BRONJ were using antibiotics (48%) or a chlorhexidine mouthrinse (84%) at enrollment. Adjusted comparisons of patients with BRONJ versus controls used multiple linear regression.
RESULTS: The average number of bisphosphonate (BP) infusions was significantly higher in patients with BRONJ compared with controls (38.4 versus 18.8, P = 0.0001). In unadjusted analyses, patients with BRONJ had more missing teeth (7.8 versus 3.1, P = 0.002) and higher average CAL (2.18 versus 1.56 mm, P = 0.047) and percentage of sites with CAL ≥3 mm (39.0 versus 23.3, P = 0.039) than controls. Also, patients with BRONJ had lower average bone height (as a fraction of tooth length, 0.59 versus 0.62, P = 0.004) and more teeth with bone height less than half of tooth length (20% versus 6%, P = 0.001). These differences remained significant after adjusting for age, sex, smoking, and number of BP infusions.
CONCLUSIONS: BRONJ patients have fewer teeth, greater CAL, and less alveolar bone support compared with controls after adjusting for number of BP infusions. Group differences in antibiotics and chlorhexidine rinse usage may have masked differences in the other clinical measures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23786404      PMCID: PMC3972496          DOI: 10.1902/jop.2013.130017

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  39 in total

1.  Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.

Authors:  J Ignacio Aguirre; Mohammed P Akhter; Donald B Kimmel; Jennifer E Pingel; Alyssa Williams; Marda Jorgensen; Lakshmyya Kesavalu; Thomas J Wronski
Journal:  J Bone Miner Res       Date:  2012-10       Impact factor: 6.741

2.  Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study.

Authors:  Nancy Lane; Gary C Armitage; Peter Loomer; Susan Hsieh; Sharmila Majumdar; H-Y Wang; Marjorie Jeffcoat; Thelma Munoz
Journal:  J Periodontol       Date:  2005-07       Impact factor: 6.993

3.  The Periodontal Disease Index (PDI).

Authors:  S P Ramfjord
Journal:  J Periodontol       Date:  1967 Nov-Dec       Impact factor: 6.993

4.  The Gingival Index, the Plaque Index and the Retention Index Systems.

Authors:  H Löe
Journal:  J Periodontol       Date:  1967 Nov-Dec       Impact factor: 6.993

Review 5.  Periodontal disease and periodontal management in patients with cancer.

Authors:  J B Epstein; P Stevenson-Moore
Journal:  Oral Oncol       Date:  2001-12       Impact factor: 5.337

6.  Effect of alendronate on periodontal disease in postmenopausal women: a randomized placebo-controlled trial.

Authors:  Miriam L Rocha; Juan M Malacara; Francisco J Sánchez-Marin; Carlos J Vazquez de la Torre; Martha E Fajardo
Journal:  J Periodontol       Date:  2004-12       Impact factor: 6.993

Review 7.  Current view of risk factors for periodontal diseases.

Authors:  R J Genco
Journal:  J Periodontol       Date:  1996-10       Impact factor: 6.993

8.  Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.

Authors:  Salvatore L Ruggiero; Bhoomi Mehrotra; Tracey J Rosenberg; Stephen L Engroff
Journal:  J Oral Maxillofac Surg       Date:  2004-05       Impact factor: 1.895

9.  A twin study of genetic variation in proportional radiographic alveolar bone height.

Authors:  B S Michalowicz; D P Aeppli; R K Kuba; J E Bereuter; J P Conry; N L Segal; T J Bouchard; B L Pihlstrom
Journal:  J Dent Res       Date:  1991-11       Impact factor: 6.116

10.  Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw.

Authors:  X Wei; S Pushalkar; C Estilo; C Wong; A Farooki; M Fornier; G Bohle; J Huryn; Y Li; S Doty; D Saxena
Journal:  Oral Dis       Date:  2012-03-23       Impact factor: 3.511

View more
  24 in total

1.  Preexisting Periapical Inflammatory Condition Exacerbates Tooth Extraction-induced Bisphosphonate-related Osteonecrosis of the Jaw Lesions in Mice.

Authors:  Minju Song; Abdullah Alshaikh; Terresa Kim; Sol Kim; Michelle Dang; Shebli Mehrazarin; Ki-Hyuk Shin; Mo Kang; No-Hee Park; Reuben H Kim
Journal:  J Endod       Date:  2016-09-13       Impact factor: 4.171

2.  The association between the severity of periodontitis and osteonecrosis of the jaw in patients with different cancer locations: a nationwide population-based study.

Authors:  Yi-Fang Huang; Kuan-Chou Lin; Shih-Ping Liu; Chung-Ta Chang; Chih-Hsin Muo; Po-Jen Chang; Chun-Hao Tsai; Ching-Zong Wu
Journal:  Clin Oral Investig       Date:  2022-04-28       Impact factor: 3.573

3.  Long-Term Ligature-Induced Periodontitis Exacerbates Development of Bisphosphonate-Related Osteonecrosis of the Jaw in Mice.

Authors:  Drake Winslow Williams; Katie Ho; Allison Lenon; Sol Kim; Terresa Kim; Yousang Gwack; Reuben H Kim
Journal:  J Bone Miner Res       Date:  2022-06-09       Impact factor: 6.390

Review 4.  Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors.

Authors:  Jason T Wan; Douglas M Sheeley; Martha J Somerman; Janice S Lee
Journal:  Bone Res       Date:  2020-03-11       Impact factor: 13.567

Review 5.  Managing Intraoral Lesions in Oral Cancer Patients in a General Dental Practice: An Overview.

Authors:  Reuben Han-Kyu Kim; Paul Yang; Eric C Sung
Journal:  J Calif Dent Assoc       Date:  2016-02

Review 6.  [Bone marrow edema and atraumatic necrosis of the femoral head : Therapy].

Authors:  J Beckmann; A Roth; C Niethard; F Mauch; R Best; U Maus
Journal:  Orthopade       Date:  2015-09       Impact factor: 1.087

7.  Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.

Authors:  Vivek Thumbigere-Math; Bryan S Michalowicz; Pamela J Hughes; David L Basi; Michaela L Tsai; Karen K Swenson; Laura Rockwell; Rajaram Gopalakrishnan
Journal:  J Oral Maxillofac Surg       Date:  2015-10-03       Impact factor: 1.895

8.  Removal of Pre-Existing Periodontal Inflammatory Condition before Tooth Extraction Ameliorates Medication-Related Osteonecrosis of the Jaw-Like Lesion in Mice.

Authors:  Terresa Kim; Sol Kim; Minju Song; Cindy Lee; Hideo Yagita; Drake W Williams; Eric C Sung; Christine Hong; Ki-Hyuk Shin; Mo K Kang; No-Hee Park; Reuben H Kim
Journal:  Am J Pathol       Date:  2018-07-27       Impact factor: 5.770

Review 9.  Dental implants in patients treated with antiresorptive medication - a systematic literature review.

Authors:  Christian Walter; Bilal Al-Nawas; Tim Wolff; Eik Schiegnitz; Knut A Grötz
Journal:  Int J Implant Dent       Date:  2016-04-04

Review 10.  Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).

Authors:  Sven Otto; Suad Aljohani; Riham Fliefel; Sara Ecke; Oliver Ristow; Egon Burian; Matthias Troeltzsch; Christoph Pautke; Michael Ehrenfeld
Journal:  Medicina (Kaunas)       Date:  2021-05-09       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.